Ceptaris Therapeutics
Pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD386m (Public information from Jul 2013)
Malvern Iowa (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $750k | Series A | |
| N/A | $500k | Early VC | |
$4.5m | Series B | ||
$14.5m | Series C | ||
| N/A | $3.1m | Early VC | |
| N/A | N/A | Early VC | |
| N/A | $14.4m | Series D | |
$15.0m | Debt | ||
$10.0m | Series D | ||
$250m Valuation: $250m | Acquisition | ||
| Total Funding | AUD73.8m | ||